Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism

Background: Sequential low molecular weight heparin (LMWH) plus warfarin, LMWH plus edoxaban, and LMWH plus dabigatran regimens have already shown efficacy and safety in the treatment of acute pulmonary embolism (PE). The efficacy and safety of sequential LMWH plus rivaroxaban regimen in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Wei, Zhao, Yunfeng, Liu, Song, Du, He, Wang, Yanmin, Li, Wenjie, Guo, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988054/
https://www.ncbi.nlm.nih.gov/pubmed/35401221
http://dx.doi.org/10.3389/fphar.2022.810455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988054/
https://www.ncbi.nlm.nih.gov/pubmed/35401221
http://dx.doi.org/10.3389/fphar.2022.810455

Ejemplares similares